Trial NCT02567396

View at ClinicalTrials.gov 
Org. Study IDs: NCI-2015-01641
Secondary IDs: 9942 NCI-2015-01641 PJC-022 UM1CA186644

Last trial update was posted on 2017-04-24

MeSH Interventions

Talazoparib

MeSH Conditions

Breast Neoplasms Carcinoma Carcinoma, Non-Small-Cell Lung Carcinoma, Ovarian Epithelial Lung Neoplasms Mesothelioma Mesothelioma, Malignant Ovarian Neoplasms Small Cell Lung Carcinoma Squamous Cell Carcinoma of Head and Neck Stomach Neoplasms

Other Conditions

Estrogen Receptor Negative HER2/Neu Negative Head and Neck Squamous Cell Carcinoma Hormone-Resistant Prostate Cancer Metastatic Pancreatic Adenocarcinoma Progesterone Receptor Negative Solid Neoplasm Stage III Mesothelioma Stage IIIA Gastric Cancer Stage IIIA Non-Small Cell Lung Cancer Stage IIIA Ovarian Cancer Stage IIIA Small Cell Lung Carcinoma Stage IIIB Gastric Cancer Stage IIIB Non-Small Cell Lung Cancer Stage IIIB Ovarian Cancer Stage IIIB Small Cell Lung Carcinoma Stage IIIC Gastric Cancer Stage IIIC Ovarian Cancer Stage IV Mesothelioma Stage IV Non-Small Cell Lung Cancer Stage IV Ovarian Cancer Stage IV Small Cell Lung Carcinoma Triple-Negative Breast Carcinoma

Stopping Reasons

Other- Protocol moved to Disapproved

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID